Chung Hoow Kok

2.2k total citations
68 papers, 800 citations indexed

About

Chung Hoow Kok is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Chung Hoow Kok has authored 68 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 36 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Chung Hoow Kok's work include Chronic Myeloid Leukemia Treatments (43 papers), Acute Myeloid Leukemia Research (25 papers) and Chronic Lymphocytic Leukemia Research (23 papers). Chung Hoow Kok is often cited by papers focused on Chronic Myeloid Leukemia Treatments (43 papers), Acute Myeloid Leukemia Research (25 papers) and Chronic Lymphocytic Leukemia Research (23 papers). Chung Hoow Kok collaborates with scholars based in Australia, United States and China. Chung Hoow Kok's co-authors include Timothy P. Hughes, Deborah L. White, Richard J. D’Andrea, David T Yeung, Verity A Saunders, David M. Ross, Anna Brown, Naranie Shanmuganathan, Agnes S. M. Yong and Luen Bik To and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Chung Hoow Kok

64 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chung Hoow Kok Australia 17 454 338 245 153 116 68 800
Brian Ball United States 14 576 1.3× 625 1.8× 397 1.6× 141 0.9× 115 1.0× 45 1.0k
Mauro Nanni Italy 16 456 1.0× 402 1.2× 294 1.2× 86 0.6× 103 0.9× 43 804
Anand Jillella United States 12 379 0.8× 456 1.3× 113 0.5× 166 1.1× 136 1.2× 48 841
Jinlan Pan China 13 369 0.8× 234 0.7× 177 0.7× 68 0.4× 92 0.8× 104 603
Jennifer Adelsperger United States 5 444 1.0× 417 1.2× 155 0.6× 101 0.7× 222 1.9× 6 793
J. Erika Haydu United States 8 407 0.9× 405 1.2× 289 1.2× 123 0.8× 85 0.7× 12 799
Dorothée Selimoglu‐Buet France 13 354 0.8× 379 1.1× 209 0.9× 108 0.7× 133 1.1× 29 692
Jorge DiMartino United States 14 588 1.3× 829 2.5× 140 0.6× 217 1.4× 117 1.0× 42 1.2k
Maher Albitar United States 14 305 0.7× 321 0.9× 287 1.2× 213 1.4× 126 1.1× 48 783
Baskar Ramdas United States 14 337 0.7× 367 1.1× 182 0.7× 92 0.6× 235 2.0× 33 723

Countries citing papers authored by Chung Hoow Kok

Since Specialization
Citations

This map shows the geographic impact of Chung Hoow Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung Hoow Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung Hoow Kok more than expected).

Fields of papers citing papers by Chung Hoow Kok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung Hoow Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung Hoow Kok. The network helps show where Chung Hoow Kok may publish in the future.

Co-authorship network of co-authors of Chung Hoow Kok

This figure shows the co-authorship network connecting the top 25 collaborators of Chung Hoow Kok. A scholar is included among the top collaborators of Chung Hoow Kok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung Hoow Kok. Chung Hoow Kok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kutyna, Monika, Joanne Yu, Anna Brown, et al.. (2025). RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome. Blood Advances. 9(16). 4244–4247. 1 indexed citations
2.
Wiseman, Thomas, Deepak Singhal, David T Yeung, et al.. (2024). Higher Rate of Red Blood Cell (RBC) Alloimmunization in RBC-Transfused Myelodysplastic Syndrome Compared to Acute Myeloid Leukemia. Blood. 144(Supplement 1). 1267–1267.
3.
Kok, Chung Hoow, Yazad Irani, Jade Clarson, et al.. (2024). CD302 predicts achievement of deep molecular response in patients with chronic myeloid leukemia treated with imatinib. PubMed. 1(2). 100014–100014. 1 indexed citations
4.
Irani, Yazad, Chung Hoow Kok, Jade Clarson, et al.. (2023). Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia. Blood Advances. 7(11). 2364–2374. 14 indexed citations
5.
Kutyna, Monika, et al.. (2023). Solute Carrier Family 29A1 Mediates In Vitro Resistance to Azacitidine in Acute Myeloid Leukemia Cell Lines. International Journal of Molecular Sciences. 24(4). 3553–3553. 3 indexed citations
6.
Kok, Chung Hoow, Verity A Saunders, Phuong Dang, et al.. (2023). Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib. Blood Cancer Journal. 13(1). 143–143. 1 indexed citations
7.
Baranwal, Anmol, Rakchha Chhetri, David T Yeung, et al.. (2023). Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study. Bone Marrow Transplantation. 58(7). 769–776. 5 indexed citations
8.
Shanmuganathan, Naranie, Carol Wadham, Daniel Thomson, et al.. (2022). RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia. Journal of Molecular Diagnostics. 24(7). 803–822. 5 indexed citations
9.
Baranwal, Anmol, Rakchha Chhetri, Chung Hoow Kok, et al.. (2022). Factors Predicting Survival Following Allogeneic Stem Cell Transplant in Patients with Therapy-Related Myeloid Neoplasms. Transplantation and Cellular Therapy. 28(3). S137–S138. 2 indexed citations
10.
Kutyna, Monika, Chung Hoow Kok, Yoon Lim, et al.. (2022). A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure. Leukemia. 36(11). 2678–2689. 15 indexed citations
11.
Shah, Mithun Vinod, Rakchha Chhetri, Chung Hoow Kok, et al.. (2022). Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms. American Journal of Hematology. 97(8). 1013–1022. 8 indexed citations
12.
Irani, Yazad, Amy Hughes, Jade Clarson, et al.. (2020). Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells. British Journal of Haematology. 191(3). 433–441. 54 indexed citations
13.
Li, Yubin, Runzhe Chen, Jian Yang, et al.. (2020). Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma. Frontiers in Genetics. 11. 814–814. 16 indexed citations
14.
Réa, Delphine, Michael J. Mauro, Jörge E. Cortes, et al.. (2020). COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study. Blood. 136(Supplement 1). 46–47. 16 indexed citations
15.
Tiong, Ing Soo, Richard Dillon, Adam Ivey, et al.. (2020). The Natural History of NPM1MUT Measurable Residual Disease (MRD) Positivity after Completion of Chemotherapy in Acute Myeloid Leukemia (AML). Blood. 136(Supplement 1). 25–27. 3 indexed citations
16.
Kok, Chung Hoow, David T Yeung, Lu Liu, et al.. (2019). Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib. Blood Advances. 3(10). 1610–1621. 23 indexed citations
17.
Pagani, Ilaria S., Chung Hoow Kok, Verity A Saunders, et al.. (2017). A Method for Next-Generation Sequencing of Paired Diagnostic and Remission Samples to Detect Mitochondrial DNA Mutations Associated with Leukemia. Journal of Molecular Diagnostics. 19(5). 711–721. 6 indexed citations
18.
Kok, Chung Hoow, Verity A Saunders, Jarrad M. Goyne, et al.. (2017). Increased peroxisome proliferator-activated receptor γ activity reduces imatinib uptake and efficacy in chronic myeloid leukemia mononuclear cells. Haematologica. 102(5). 843–853. 11 indexed citations
19.
Jabbour, Anissa M., et al.. (2012). p53-Dependent Transcriptional Responses to Interleukin-3 Signaling. PLoS ONE. 7(2). e31428–e31428. 7 indexed citations
20.
Brown, Anna, Teresa Sadras, Chung Hoow Kok, et al.. (2011). The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation. Differentiation. 83(1). 47–59. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Ball Breakdown of academic impact, for papers by Mauro Nanni Breakdown of academic impact, for papers by Anand Jillella Breakdown of academic impact, for papers by Jinlan Pan Breakdown of academic impact, for papers by Jennifer Adelsperger Breakdown of academic impact, for papers by J. Erika Haydu Breakdown of academic impact, for papers by Dorothée Selimoglu‐Buet Breakdown of academic impact, for papers by Jorge DiMartino Breakdown of academic impact, for papers by Maher Albitar Breakdown of academic impact, for papers by Baskar Ramdas
Rankless by CCL
2026